Please Wait
Applying Filters...
menu
    • menu
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Obefazimod

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abivax Reports Q1 2026 Results and 3-Year Obefazimod OLE Data
    Abivax Reports Q1 2026 Results and 3-Year Obefazimod OLE Data

    22 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/22/3300344/0/en/abivax-presents-first-quarter-2026-financial-results-and-reports-three-year-interim-data-from-study-108-a-phase-2a-2b-open-label-extension-trial-of-obefazimod-following-dose-de-esc.html

    GLOBENEWSWIRE
    22 May 2026
    Share Share
    Abivax To Present Data On Obefazimod At Digestive Disease Week
    Abivax To Present Data On Obefazimod At Digestive Disease Week

    22 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/22/3279387/0/en/abivax-to-present-data-on-obefazimod-at-digestive-disease-week.html

    GLOBENEWSWIRE
    22 Apr 2026
    Share Share
    Abivax Reveals 2025 Financials And Business Updates
    Abivax Reveals 2025 Financials And Business Updates

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260837/0/en/Abivax-Announces-Full-Year-2025-Financial-Results-and-Provides-Business-Updates.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    Abivax Unveils Obefazimod's Anti-Fibrotic Activity In IBD
    Abivax Unveils Obefazimod's Anti-Fibrotic Activity In IBD

    21 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/21/3242210/0/en/Abivax-Presents-First-Evidence-of-Anti-Fibrotic-Activity-for-Obefazimod-Alongside-New-Clinical-Efficacy-and-Safety-Analyses-in-Inflammatory-Bowel-Disease-at-ECCO-2026.html

    GLOBENEWSWIRE
    21 Feb 2026
    Share Share
    Abivax Provides 2026 Corporate Outlook
    Abivax Provides 2026 Corporate Outlook

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214893/0/en/Abivax-Provides-2026-Corporate-Outlook.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Abivax to Present 22 Obefazimod Abstracts in IBD at ECCO 2026
    Abivax to Present 22 Obefazimod Abstracts in IBD at ECCO 2026

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3207315/0/en/Abivax-Announces-Acceptance-of-22-Abstracts-Evaluating-Obefazimod-in-Inflammatory-Bowel-Disease-at-ECCO-2026-Featuring-an-Oral-Presentation-on-Preclinical-Anti-Fibrotic-Findings.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.